YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FJGP4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,889
Award facts
- Contract value 100% obligated
- $1,888.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,888.62 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The contract is a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of January 13, 2026. This award was issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group holds a single-award IDC under the PPV-G GEN V initiative with a $499.999 billion ceiling value extending through December 31, 2036, positioning the company as a critical regional pharmaceutical supplier. The company's extensive product portfolio spans branded and generic prescription medications, biologics, vaccines, and medical consumables. As an established federal pharmaceutical supplier with consistent delivery order performance since October 2025, DMS Pharmaceutical Group leverages its small business status to provide diverse pharmaceutical products supporting Department of Defense military healthcare operations globally through the DLA Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FJGP4?
SPE2DR26FJGP4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FJGP4 worth?
The government has obligated $1,889 on SPE2DR26FJGP4.
Is contract SPE2DR26FJGP4 an order under another contract?
Yes. SPE2DR26FJGP4 is a delivery order under SPE2DR25D9150, an indefinite delivery contract.
Was contract SPE2DR26FJGP4 competed?
The extent of competition for SPE2DR26FJGP4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award